Skip to main content
Premium Trial:

Request an Annual Quote

Pathway Genomics Partners with Parkway

NEW YORK (GenomeWeb News) – Pathway Genomics today said that Parkway Laboratory Services will offer the firm's Pathway Fit nutrigenetic test in Singapore.

According to San Diego-based Pathway, its Pathway Fit test reports on a patient's "genetic propensity for diet, nutritional needs, metabolic health factors, and food reactions. The firm noted that all DNA analysis and interpretation of the test is conducted at its CLIA-certified lab.

Further terms of the agreement were not disclosed.

Singapore-based Parkway operates labs in several hospitals and medical centers and provides clinical lab, histopathology, and genetic testing services.

The Scan

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.

Breast Cancer Risk Gene Candidates Found by Multi-Ancestry Low-Frequency Variant Analysis

Researchers narrowed in on new and known risk gene candidates with variant profiles for almost 83,500 individuals with breast cancer and 59,199 unaffected controls in Genome Medicine.

Health-Related Quality of Life Gets Boost After Microbiome-Based Treatment for Recurrent C. Diff

A secondary analysis of Phase 3 clinical trial data in JAMA Network Open suggests an investigational oral microbiome-based drug may lead to enhanced quality of life measures.

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.